TSS
TEVA icon

Two Sigma Securities’s Teva Pharmaceuticals TEVA Stock Holding History

Two Sigma Securities’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-34,200
Closed -$616K – 3129
2024
Q3 		$616K Sell
34,200
-79,300
-70% -$1.39M 0.01% 1165
2024
Q2 		$1.84M Sell
113,500
-112,500
-50% -$1.73M 0.02% 751
2024
Q1 		$3.19M Buy
226,000
+204,900
+971% +$2.58M 0.03% 553
2023
Q4 		$220K Buy
+21,100
New +$197K ﹤0.01% 2299
2022
Q4 		– Sell
-40,600
Closed -$328K – 3249
2022
Q3 		$328K Buy
+40,600
New +$359K 0.01% 1485
2021
Q3 		– Sell
-22,600
Closed -$224K – 1954
2021
Q2 		$224K Buy
+22,600
New +$239K 0.01% 1210
2021
Q1 		– Sell
-67,300
Closed -$649K – 1702
2020
Q4 		$649K Buy
+67,300
New +$645K 0.02% 574
2020
Q2 		– Sell
-63,300
Closed -$568K – 1731
2020
Q1 		$568K Buy
+63,300
New +$649K 0.01% 573
2019
Q3 		– Sell
-52,300
Closed -$483K – 2450
2019
Q2 		$483K Sell
52,300
-144,300
-73% -$1.74M 0.01% 1139
2019
Q1 		$3.08M Buy
196,600
+23,800
+14% +$420K 0.03% 236
2018
Q4 		$2.67M Sell
172,800
-424,300
-71% -$8.7M 0.03% 275
2018
Q3 		$12.9M Buy
597,100
+56,500
+10% +$1.31M 0.08% 161
2018
Q2 		$13.1M Sell
540,600
-205,900
-28% -$4.2M 0.07% 222
2018
Q1 		$12.8M Buy
746,500
+700,600
+1,526% +$13.7M 0.07% 229
2017
Q4 		$870K Buy
+45,900
New +$690K 0.02% 467

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Two Sigma Securities's TEVA Position: Q3 2024 in Review

Two Sigma Securities sold out of Teva Pharmaceuticals (TEVA) in Q3 2024, closing a stake of 16,253 shares — an estimated $284K sold.

Two Sigma Securities first reported a position in TEVA in Q1 2016 and held it in 25 quarters. The position peaked at $2.54M in Q3 2016. 542 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • Two Sigma Securities reported no remaining Teva Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Securities sold 16,253 Teva Pharmaceuticals shares in Q3 2024, an estimated $284K.
  • Two Sigma Securities first reported a position in Teva Pharmaceuticals in Q1 2016 and held it in 25 quarters.
  • Two Sigma Securities's Teva Pharmaceuticals position peaked at $2.54M in Q3 2016.
  • 542 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.